Current Clinical Trials

Ophthotech

Palmetto Retina - Wednesday, March 21, 2018

OPH 2003: A Phase 2/3 Randomized, Double-Masked, Controlled Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura® (Anti-C5 Aptamer) in Subjects with Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

OPH 2005: A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects with Autosomal Recessive Stargardt Disease

Trackback Link
http://www.palmettoretina.com/BlogRetrieve.aspx?BlogID=11185&PostID=753457&A=Trackback
Trackbacks
Post has no trackbacks.

0

Combined Years of Practice

0

Operations Performed

0

Clinical Trials Participated

0

Offices

Our Physicians

Take a few moments to meet the skilled physicians of Palmetto Retina, P.A.

Please Contact Us For More Information

(803) 931-0077 | (888) 931-0077